Alejandra Negro
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 14
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 5
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Co-authors
- Ghassan K. Abou‐Alfa (16 shared papers)Robin Kate Kelley (14 shared papers)Bruno Sangro (10 shared papers)Stephen L. Chan (4 shared papers)Philip He (6 shared papers)Junji Furuse (5 shared papers)Masatoshi Kudo (5 shared papers)Yoon‐Koo Kang (3 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Annals of Oncology (7 papers)Clinical Cancer Research (1 paper)The Journal of Clinical Pharmacology (1 paper)Oral Diseases (1 paper)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Alejandra Negro
32 papers receiving 851 citations
Alejandra Negro's Hit Papers
Peers
Comparison fields: 5 of 65
- Hepatology 395
- Oncology 492
- Gastroenterology 52
- Pathology and Forensic Medicine 136
- Pulmonary and Respiratory Medicine 226
Countries citing papers authored by Alejandra Negro
This map shows the geographic impact of Alejandra Negro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Negro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Negro more than expected).
Fields of papers citing papers by Alejandra Negro
This network shows the impact of papers produced by Alejandra Negro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Negro. The network helps show where Alejandra Negro may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandra Negro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. Hit paper breakdown → | 2022 | 259 |
| 2 | 2004 | 151 | |
| 3 | 2020 | 82 | |
| 4 | 2018 | 78 | |
| 5 | 2022 | 77 | |
| 6 | 2006 | 40 | |
| 7 | 2021 | 27 | |
| 8 | 2022 | 21 | |
| 9 | 2024 | 20 | |
| 10 | 2011 | 20 | |
| 11 | 2021 | 15 | |
| 12 | 2022 | 14 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 4 |
About Alejandra Negro
Alejandra Negro is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 34 papers that have together received 863 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Colorectal Cancer Treatments and Studies (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Esophageal Cancer Research and Treatment (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Hepatology (395 citations), Oncology (492 citations), Gastroenterology (52 citations), Pathology and Forensic Medicine (136 citations) and Pulmonary and Respiratory Medicine (226 citations). Alejandra Negro has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Ghassan K. Abou‐Alfa, Robin Kate Kelley, Bruno Sangro, Stephen L. Chan, Philip He, Junji Furuse, Masatoshi Kudo, Yoon‐Koo Kang, Enrico N. De Toni and George Lau. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, The Journal of Clinical Pharmacology and Oral Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.